Clinical Trial Update: 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of triple therapy with olmesartan, amlodipine, and hydrochlorothiazide in patients with Type 2 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Olmesartan (olmesartan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes, Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-07-02